False Daisy (Eclipta prostrata)

False daisy (Eclipta prostrata) is an Ayurvedic herb whose primary bioactive compound, wedelolactone, inhibits NF-κB signaling to exert hepatoprotective and anti-inflammatory effects. Triterpenoids and ecliptasaponins further contribute to its antitumor and hair-regenerative properties observed in preclinical models.

Origin & History

False Daisy, or Eclipta prostrata, is a herbaceous plant from the Asteraceae family, found in tropical and subtropical regions globally. It is harvested for its whole plant, which is then extracted using solvents like methanol or ethanol for analysis of its active compounds.

Historical & Cultural Context

False Daisy, known as Bhringaraj in Ayurveda, has been historically used in Indian traditional medicine for liver protection and hair growth. It is also utilized in traditional Chinese medicine and by tribal communities in India for various health applications.[3][4][6]

Health Benefits

• Liver protection: Preclinical studies indicate antifibrotic effects via wedelolactone's action on NF-κB.[3] • Potential hair growth benefits: Traditional uses suggest efficacy, though lacking clinical validation.[3][4] • Antitumor activity: In vitro studies show triterpenoids reduce tumor growth in liver cells.[3] • Chemotherapy resistance reduction: Eclipta prostrata modulates P-glycoprotein in vitro, potentially aiding chemotherapy.[3] • Anti-inflammatory effects: Wedelolactone represses liver inflammation in preclinical models.[3]

How It Works

Wedelolactone, a coumestan compound in Eclipta prostrata, suppresses NF-κB activation by blocking IκB kinase (IKK), thereby reducing pro-inflammatory cytokine release and hepatic stellate cell activation linked to liver fibrosis. Triterpenoids such as eclalbasaponin inhibit tumor cell proliferation by inducing apoptosis via caspase-3 and caspase-9 pathways in vitro. Phytosterols and polypeptides present in the herb are hypothesized to stimulate dermal papilla cells and upregulate Wnt/β-catenin signaling, potentially supporting hair follicle cycling.

Scientific Research

There are no specific human clinical trials or meta-analyses available for False Daisy. Current evidence is primarily from preclinical and in vitro/in vivo studies.[1][2][3]

Clinical Summary

The majority of evidence supporting Eclipta prostrata comes from in vitro cell studies and rodent models, with no large-scale randomized controlled trials in humans published to date. Animal studies using hepatotoxin-induced liver injury models (CCl4 and thioacetamide) demonstrated significant reductions in serum ALT and AST levels, as well as decreased hepatic collagen deposition at doses of 200–400 mg/kg. A small number of pilot human studies on hair oil formulations containing E. prostrata showed modest improvements in hair density, but these lacked placebo controls and standardized dosing. Overall, the evidence base is promising but preliminary, and clinical validation through rigorous human trials remains insufficient.

Nutritional Profile

Eclipta prostrata (Bhringraj) is utilized primarily as a medicinal herb rather than a food source, so conventional macronutrient profiling is limited. Its therapeutic value derives from its rich bioactive phytochemical composition rather than caloric or macronutrient content. Key compounds include: • **Coumestans:** Wedelolactone (0.4–3.0% of dry weight depending on plant part and extraction method) and demethylwedelolactone — these are the principal hepatoprotective and anti-inflammatory constituents, acting as potent NF-κB inhibitors and 5-lipoxygenase inhibitors. • **Triterpenoid saponins:** Eclalbasaponins I–VI and ecliptasaponins A–D, contributing to antitumor and anti-inflammatory activity. • **Thiophene derivatives:** Including α-terthienylmethanol and related polyacetylenes with demonstrated antimicrobial and photodynamic activity. • **Steroidal alkaloids:** Ecliptine and nicotine (trace amounts). • **Flavonoids:** Luteolin, apigenin, and their glycosides (luteolin-7-O-glucoside), providing antioxidant capacity. Estimated total flavonoid content ~15–25 mg quercetin equivalents per gram of dry extract. • **Phenolic acids:** Protocatechuic acid, 4-hydroxybenzoic acid, and caffeic acid derivatives. Total phenolic content approximately 40–80 mg gallic acid equivalents per gram of dry extract. • **Vitamins and minerals (whole herb):** Contains ascorbic acid (~30–50 mg/100 g fresh weight), β-carotene (precursor to vitamin A), iron (~15–20 mg/100 g dry weight), calcium (~300–400 mg/100 g dry weight), and magnesium. Also contains small amounts of riboflavin and nicotinic acid. • **Phytosterols:** β-sitosterol, stigmasterol, and daucosterol. • **Volatile constituents:** Including heptadecane, 6,9-heptadecadiene, and wedelic acid. • **Fiber:** Crude fiber approximately 10–15% of dry weight in whole herb. • **Protein:** Crude protein approximately 15–20% of dry weight. • **Bioavailability notes:** Wedelolactone has moderate oral bioavailability limited by poor aqueous solubility (~0.2 mg/mL); bioavailability is enhanced by lipid-based formulations or traditional preparations using sesame oil (taila). Coumestans undergo hepatic first-pass metabolism. Traditional Ayurvedic processing (e.g., bhringraj taila or swarasa/fresh juice extraction) may improve the bioaccessibility of lipophilic compounds. The thiophene derivatives are photosensitive and may degrade with light exposure, affecting potency in poorly stored preparations.

Preparation & Dosage

No clinically studied dosage ranges are available due to the absence of human trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Ashwagandha, Turmeric, Triphala, Aloe Vera, Licorice Root

Safety & Interactions

Eclipta prostrata is generally considered safe at traditional dietary doses, but high-dose supplementation may cause gastrointestinal discomfort including nausea and loose stools. Because wedelolactone inhibits NF-κB, concurrent use with immunosuppressants such as corticosteroids or cyclosporine may produce additive effects warranting medical supervision. The herb has demonstrated uterotonic activity in animal models, making it contraindicated during pregnancy without physician oversight. Individuals taking anticoagulants like warfarin should exercise caution, as coumestan compounds structurally related to coumarin may theoretically potentiate bleeding risk.